nodes	percent_of_prediction	percent_of_DWPC	metapath
Arbutamine—ADRB3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0381	0.0382	CbGpPWpGaD
Arbutamine—ADRB3—G alpha (s) signalling events—P2RY11—narcolepsy	0.0278	0.0279	CbGpPWpGaD
Arbutamine—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0226	0.0227	CbGpPWpGaD
Arbutamine—ADRB3—Monoamine GPCRs—HTR2A—narcolepsy	0.0226	0.0227	CbGpPWpGaD
Arbutamine—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.0221	0.0222	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.0207	0.0208	CbGpPWpGaD
Arbutamine—ADRB3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.019	0.019	CbGpPWpGaD
Arbutamine—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.0165	0.0166	CbGpPWpGaD
Arbutamine—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.0162	0.0162	CbGpPWpGaD
Arbutamine—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.016	0.0161	CbGpPWpGaD
Arbutamine—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.016	0.0161	CbGpPWpGaD
Arbutamine—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0155	0.0155	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0137	0.0138	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0137	0.0138	CbGpPWpGaD
Arbutamine—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.0134	0.0135	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0133	0.0133	CbGpPWpGaD
Arbutamine—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.0131	0.0132	CbGpPWpGaD
Arbutamine—ADRB3—G alpha (s) signalling events—NPS—narcolepsy	0.013	0.0131	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Arbutamine—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0113	0.0113	CbGpPWpGaD
Arbutamine—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.011	0.0111	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—HCRTR1—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—HCRTR2—narcolepsy	0.0105	0.0105	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—P2RY11—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0101	0.0101	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00952	0.00954	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00952	0.00954	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00932	0.00933	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00932	0.00933	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0092	0.00922	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.009	0.00901	CbGpPWpGaD
Arbutamine—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00876	0.00877	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—HCRT—narcolepsy	0.0086	0.00861	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00856	0.00857	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00816	0.00818	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00816	0.00818	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00798	0.008	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00798	0.008	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00788	0.0079	CbGpPWpGaD
Arbutamine—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.00774	0.00775	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00771	0.00772	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—PENK—narcolepsy	0.00766	0.00768	CbGpPWpGaD
Arbutamine—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.00757	0.00758	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0075	0.00752	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0067	0.00671	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00655	0.00657	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—TRH—narcolepsy	0.00651	0.00653	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00622	0.00623	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00622	0.00623	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.00621	0.00623	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.00621	0.00623	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.00608	0.00609	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.00608	0.00609	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.006	0.00601	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00597	0.00598	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00592	0.00593	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00592	0.00593	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.00587	0.00588	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00584	0.00585	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.00583	0.00584	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—P2RY11—narcolepsy	0.00571	0.00572	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—HRH3—narcolepsy	0.00571	0.00572	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HCRTR2—narcolepsy	0.00537	0.00538	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HCRTR1—narcolepsy	0.00537	0.00538	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0052	0.00521	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—P2RY11—narcolepsy	0.00519	0.0052	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.0051	0.00511	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00508	0.00509	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00508	0.00509	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.00499	0.005	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00497	0.00498	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—HCRT—narcolepsy	0.00486	0.00487	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—NPS—narcolepsy	0.00473	0.00474	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—TAC1—narcolepsy	0.00473	0.00474	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.00455	0.00456	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00445	0.00446	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.00445	0.00446	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HCRT—narcolepsy	0.00441	0.00442	CbGpPWpGaD
Arbutamine—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00436	0.00437	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00436	0.00436	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—PENK—narcolepsy	0.00433	0.00434	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—PENK—narcolepsy	0.00393	0.00394	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.00387	0.00387	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.00378	0.00379	CbGpPWpGaD
Arbutamine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00374	0.00375	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00369	0.0037	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00369	0.0037	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—TRH—narcolepsy	0.00368	0.00369	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00361	0.00362	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00361	0.00362	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00351	0.00352	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00351	0.00352	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00343	0.00344	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00343	0.00344	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00339	0.0034	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00339	0.0034	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—TRH—narcolepsy	0.00334	0.00335	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.00332	0.00332	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—HRH3—narcolepsy	0.00323	0.00323	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.00319	0.00319	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HCRTR2—narcolepsy	0.00317	0.00318	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HCRTR1—narcolepsy	0.00317	0.00318	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.00312	0.00313	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.00312	0.00313	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.00308	0.00309	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—P2RY11—narcolepsy	0.00306	0.00307	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.00301	0.00302	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HRH3—narcolepsy	0.00293	0.00294	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.00288	0.00289	CbGpPWpGaD
Arbutamine—ADRB3—GPCR ligand binding—HTR2A—narcolepsy	0.00285	0.00285	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.00282	0.00283	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.00281	0.00282	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.00281	0.00282	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—TAC1—narcolepsy	0.00267	0.00268	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—NPS—narcolepsy	0.00267	0.00268	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HCRT—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Arbutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00259	0.0026	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.00257	0.00258	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.00256	0.00257	CbGpPWpGaD
Arbutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00253	0.00254	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.00251	0.00252	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—TAC1—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—NPS—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00233	0.00234	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PENK—narcolepsy	0.00232	0.00233	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.00228	0.00229	CbGpPWpGaD
Arbutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Arbutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00217	0.00218	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.00198	0.00199	CbGpPWpGaD
Arbutamine—Epinephrine—TNF—narcolepsy	0.00198	1	CrCbGaD
Arbutamine—ADRB3—Signaling Pathways—TRH—narcolepsy	0.00197	0.00198	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.00188	0.00189	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.00188	0.00189	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.00187	0.00188	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.00184	0.00185	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.00184	0.00185	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—P2RY11—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HRH3—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HRH3—narcolepsy	0.00173	0.00174	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HRH3—narcolepsy	0.0017	0.00171	CbGpPWpGaD
Arbutamine—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Arbutamine—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	0.00165	0.00166	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—NPS—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—NPS—narcolepsy	0.00155	0.00156	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	0.00155	0.00156	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HCRT—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HCRT—narcolepsy	0.00151	0.00152	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HTR2A—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—NPS—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—TAC1—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TAC1—narcolepsy	0.00143	0.00144	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NPS—narcolepsy	0.00143	0.00144	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PENK—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PENK—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TRH—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TRH—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HRH3—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HRH3—narcolepsy	0.00101	0.00101	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	0.000955	0.000957	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	0.000934	0.000936	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	0.000867	0.000869	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HTR2A—narcolepsy	0.000863	0.000865	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TAC1—narcolepsy	0.000852	0.000853	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NPS—narcolepsy	0.000852	0.000853	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	0.000848	0.00085	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TAC1—narcolepsy	0.000833	0.000835	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NPS—narcolepsy	0.000833	0.000835	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HTR2A—narcolepsy	0.000512	0.000513	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HTR2A—narcolepsy	0.000501	0.000502	CbGpPWpGaD
